← Eichor
Study identifier: NCT06287775 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Condition: Extensive Stage Lung Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8  ·  Sponsor: National Cancer Institute (NCI)

PhasePhase 1/Phase 2
Planned participants45
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This phase I/II trial tests the safety, side effects, and best dose of iadademstat when given together with atezolizumab or durvalumab, and studies the effect of the combination in treating patients with small cell lung cancer that has spread outside of the lung in which it began or to other parts of the body (extensive stage) who initially received standard of care chemotherapy and immunotherapy. Iadademstat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as atezolizumab or durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding iadademstat to either atezolizumab or durvalumab may be able to stabilize cancer for longer than atezolizumab or durvalumab alone in treating patients with extensive stage small cell lung cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (43)

City of Hope Comprehensive Cancer CenterDuarte, California, United StatesRecruiting
City of Hope at Irvine LennarIrvine, California, United StatesRecruiting
UC San Diego Moores Cancer CenterLa Jolla, California, United StatesRecruiting
University of California Davis Comprehensive Cancer CenterSacramento, California, United StatesRecruiting
Smilow Cancer Hospital Care Center at Saint FrancisHartford, Connecticut, United StatesSuspended
Yale UniversityNew Haven, Connecticut, United StatesRecruiting
Yale-New Haven Hospital North Haven Medical CenterNorth Haven, Connecticut, United StatesRecruiting
Smilow Cancer Hospital Care Center at Long RidgeStamford, Connecticut, United StatesSuspended
Smilow Cancer Hospital Care Center-TrumbullTrumbull, Connecticut, United StatesRecruiting
MedStar Georgetown University HospitalWashington D.C., District of Columbia, United StatesRecruiting
UF Health Cancer Institute - GainesvilleGainesville, Florida, United StatesRecruiting
Moffitt Cancer CenterTampa, Florida, United StatesSuspended

+ 31 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06287775